nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.121	0.392	CbGbCtD
Prednisone—NR3C1—Progesterone—uterine cancer	0.0802	0.26	CbGbCtD
Prednisone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0444	0.0877	CrCrCtD
Prednisone—Potassium Canrenoate—Progesterone—uterine cancer	0.0387	0.0764	CrCrCtD
Prednisone—Danazol—Progesterone—uterine cancer	0.0327	0.0645	CrCrCtD
Prednisone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0326	0.0644	CrCrCtD
Prednisone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0316	0.0624	CrCrCtD
Prednisone—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0307	0.0605	CrCrCtD
Prednisone—Hydrocortamate—Progesterone—uterine cancer	0.0284	0.0561	CrCrCtD
Prednisone—Cortisone acetate—Progesterone—uterine cancer	0.0276	0.0544	CrCrCtD
Prednisone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0275	0.0542	CrCrCtD
Prednisone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0268	0.0528	CrCrCtD
Prednisone—Testolactone—Progesterone—uterine cancer	0.0267	0.0528	CrCrCtD
Prednisone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0255	0.0503	CrCrCtD
Prednisone—Fludrocortisone—Progesterone—uterine cancer	0.0239	0.0473	CrCrCtD
Prednisone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0238	0.0471	CrCrCtD
Prednisone—Methyltestosterone—Progesterone—uterine cancer	0.0233	0.0461	CrCrCtD
Prednisone—CYP2C19—Progesterone—uterine cancer	0.0231	0.075	CbGbCtD
Prednisone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0224	0.0442	CrCrCtD
Prednisone—Prednisolone—Progesterone—uterine cancer	0.0203	0.0402	CrCrCtD
Prednisone—Hydrocortisone—Progesterone—uterine cancer	0.0195	0.0385	CrCrCtD
Prednisone—ABCB1—Progesterone—uterine cancer	0.0187	0.0605	CbGbCtD
Prednisone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0169	0.0548	CbGbCtD
Prednisone—ABCB1—Dactinomycin—uterine cancer	0.0148	0.048	CbGbCtD
Prednisone—CYP3A4—Progesterone—uterine cancer	0.0112	0.0363	CbGbCtD
Prednisone—ABCB1—Etoposide—uterine cancer	0.00836	0.0271	CbGbCtD
Prednisone—ABCB1—Doxorubicin—uterine cancer	0.0057	0.0185	CbGbCtD
Prednisone—CYP3A4—Etoposide—uterine cancer	0.00501	0.0162	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—uterine cancer	0.00342	0.0111	CbGbCtD
Prednisone—HSD11B1—myometrium—uterine cancer	0.00297	0.104	CbGeAlD
Prednisone—HSD11B1—smooth muscle tissue—uterine cancer	0.00225	0.0783	CbGeAlD
Prednisone—HSD11B1—decidua—uterine cancer	0.0022	0.0768	CbGeAlD
Prednisone—HSD11B1—renal system—uterine cancer	0.00216	0.0754	CbGeAlD
Prednisone—HSD11B1—mammalian vulva—uterine cancer	0.00202	0.0705	CbGeAlD
Prednisone—HSD11B1—uterus—uterine cancer	0.00193	0.0672	CbGeAlD
Prednisone—HSD11B1—female reproductive system—uterine cancer	0.00173	0.0604	CbGeAlD
Prednisone—HSD11B1—female gonad—uterine cancer	0.00158	0.0549	CbGeAlD
Prednisone—HSD11B1—vagina—uterine cancer	0.00157	0.0546	CbGeAlD
Prednisone—HSD11B1—lymph node—uterine cancer	0.00101	0.0353	CbGeAlD
Prednisone—SLCO1A2—renal system—uterine cancer	0.000654	0.0228	CbGeAlD
Prednisone—NR3C1—myometrium—uterine cancer	0.000562	0.0196	CbGeAlD
Prednisone—Danazol—CCL2—uterine cancer	0.000459	0.16	CrCbGaD
Prednisone—NR3C1—epithelium—uterine cancer	0.000441	0.0154	CbGeAlD
Prednisone—NR3C1—uterine cervix—uterine cancer	0.000438	0.0153	CbGeAlD
Prednisone—NR3C1—smooth muscle tissue—uterine cancer	0.000425	0.0148	CbGeAlD
Prednisone—Exemestane—CYP19A1—uterine cancer	0.000417	0.146	CrCbGaD
Prednisone—NR3C1—decidua—uterine cancer	0.000417	0.0145	CbGeAlD
Prednisone—NR3C1—renal system—uterine cancer	0.000409	0.0143	CbGeAlD
Prednisone—Testolactone—CYP19A1—uterine cancer	0.000398	0.139	CrCbGaD
Prednisone—NR3C1—endometrium—uterine cancer	0.000396	0.0138	CbGeAlD
Prednisone—NR3C1—mammalian vulva—uterine cancer	0.000383	0.0133	CbGeAlD
Prednisone—CYP2C19—vagina—uterine cancer	0.000379	0.0132	CbGeAlD
Prednisone—NR3C1—uterus—uterine cancer	0.000365	0.0127	CbGeAlD
Prednisone—NR3C1—female reproductive system—uterine cancer	0.000328	0.0114	CbGeAlD
Prednisone—CYP3A4—renal system—uterine cancer	0.00031	0.0108	CbGeAlD
Prednisone—ALB—lymph node—uterine cancer	0.000305	0.0106	CbGeAlD
Prednisone—ABCB1—myometrium—uterine cancer	0.000301	0.0105	CbGeAlD
Prednisone—NR3C1—female gonad—uterine cancer	0.000298	0.0104	CbGeAlD
Prednisone—NR3C1—vagina—uterine cancer	0.000297	0.0103	CbGeAlD
Prednisone—Danazol—PGR—uterine cancer	0.000279	0.0975	CrCbGaD
Prednisone—CYP3A4—female reproductive system—uterine cancer	0.000248	0.00864	CbGeAlD
Prednisone—ABCB1—epithelium—uterine cancer	0.000236	0.00824	CbGeAlD
Prednisone—ABCB1—uterine cervix—uterine cancer	0.000234	0.00817	CbGeAlD
Prednisone—Betamethasone—PGR—uterine cancer	0.000228	0.0794	CrCbGaD
Prednisone—ABCB1—decidua—uterine cancer	0.000223	0.00778	CbGeAlD
Prednisone—ABCB1—renal system—uterine cancer	0.000219	0.00764	CbGeAlD
Prednisone—ABCB1—endometrium—uterine cancer	0.000212	0.00739	CbGeAlD
Prednisone—ABCB1—mammalian vulva—uterine cancer	0.000205	0.00714	CbGeAlD
Prednisone—ABCB1—uterus—uterine cancer	0.000195	0.00681	CbGeAlD
Prednisone—NR3C1—lymph node—uterine cancer	0.000192	0.00669	CbGeAlD
Prednisone—Danazol—CYP19A1—uterine cancer	0.000192	0.0669	CrCbGaD
Prednisone—Danazol—ESR1—uterine cancer	0.000176	0.0615	CrCbGaD
Prednisone—Dexamethasone—CYP11A1—uterine cancer	0.000176	0.0613	CrCbGaD
Prednisone—ABCB1—female reproductive system—uterine cancer	0.000176	0.00612	CbGeAlD
Prednisone—Methyltestosterone—CYP19A1—uterine cancer	0.000162	0.0565	CrCbGaD
Prednisone—ABCB1—female gonad—uterine cancer	0.00016	0.00557	CbGeAlD
Prednisone—ABCB1—vagina—uterine cancer	0.000159	0.00553	CbGeAlD
Prednisone—Betamethasone—CYP19A1—uterine cancer	0.000156	0.0545	CrCbGaD
Prednisone—Dexamethasone—PGR—uterine cancer	0.000132	0.0462	CrCbGaD
Prednisone—ALB—Selenium Micronutrient Network—GPX3—uterine cancer	0.000116	0.00234	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000115	0.00231	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKR1C3—uterine cancer	0.000114	0.00231	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	0.000113	0.00228	CbGpPWpGaD
Prednisone—Pulmonary oedema—Epirubicin—uterine cancer	0.00011	0.00106	CcSEcCtD
Prednisone—Skin exfoliation—Doxorubicin—uterine cancer	0.000109	0.00105	CcSEcCtD
Prednisone—Pruritus—Progesterone—uterine cancer	0.000109	0.00105	CcSEcCtD
Prednisone—Oedema—Dactinomycin—uterine cancer	0.000109	0.00105	CcSEcCtD
Prednisone—Fluid retention—Doxorubicin—uterine cancer	0.000109	0.00105	CcSEcCtD
Prednisone—Infection—Dactinomycin—uterine cancer	0.000108	0.00104	CcSEcCtD
Prednisone—Neuropathy—Doxorubicin—uterine cancer	0.000107	0.00104	CcSEcCtD
Prednisone—Sepsis—Epirubicin—uterine cancer	0.000107	0.00104	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000107	0.00215	CbGpPWpGaD
Prednisone—Diarrhoea—Progesterone—uterine cancer	0.000105	0.00102	CcSEcCtD
Prednisone—Oesophagitis—Doxorubicin—uterine cancer	0.000105	0.00101	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	0.000104	0.00209	CbGpPWpGaD
Prednisone—Thrombophlebitis—Epirubicin—uterine cancer	0.000104	0.001	CcSEcCtD
Prednisone—Anorexia—Dactinomycin—uterine cancer	0.000104	0.001	CcSEcCtD
Prednisone—Eye disorder—Etoposide—uterine cancer	0.000104	0.000999	CcSEcCtD
Prednisone—Ecchymosis—Doxorubicin—uterine cancer	0.000103	0.000998	CcSEcCtD
Prednisone—Diabetes mellitus—Epirubicin—uterine cancer	0.000103	0.000996	CcSEcCtD
Prednisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	0.000103	0.00208	CbGpPWpGaD
Prednisone—Flushing—Etoposide—uterine cancer	0.000103	0.000992	CcSEcCtD
Prednisone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000103	0.000991	CcSEcCtD
Prednisone—ABCB1—lymph node—uterine cancer	0.000103	0.00358	CbGeAlD
Prednisone—Pulmonary oedema—Doxorubicin—uterine cancer	0.000102	0.000983	CcSEcCtD
Prednisone—Dizziness—Progesterone—uterine cancer	0.000102	0.000982	CcSEcCtD
Prednisone—Angiopathy—Etoposide—uterine cancer	0.000101	0.00097	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	0.0001	0.00202	CbGpPWpGaD
Prednisone—Vascular purpura—Epirubicin—uterine cancer	0.0001	0.000968	CcSEcCtD
Prednisone—Immune system disorder—Etoposide—uterine cancer	0.0001	0.000965	CcSEcCtD
Prednisone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0001	0.000965	CcSEcCtD
Prednisone—Sepsis—Doxorubicin—uterine cancer	9.93e-05	0.000958	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	9.91e-05	0.000956	CcSEcCtD
Prednisone—Cardiac failure congestive—Epirubicin—uterine cancer	9.9e-05	0.000955	CcSEcCtD
Prednisone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	9.87e-05	0.000952	CcSEcCtD
Prednisone—Alopecia—Etoposide—uterine cancer	9.79e-05	0.000944	CcSEcCtD
Prednisone—Vomiting—Progesterone—uterine cancer	9.79e-05	0.000944	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	9.77e-05	0.00197	CbGpPWpGaD
Prednisone—Rash—Progesterone—uterine cancer	9.71e-05	0.000936	CcSEcCtD
Prednisone—Dermatitis—Progesterone—uterine cancer	9.7e-05	0.000935	CcSEcCtD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.67e-05	0.00195	CbGpPWpGaD
Prednisone—Headache—Progesterone—uterine cancer	9.64e-05	0.00093	CcSEcCtD
Prednisone—Thrombophlebitis—Doxorubicin—uterine cancer	9.6e-05	0.000926	CcSEcCtD
Prednisone—Increased appetite—Epirubicin—uterine cancer	9.56e-05	0.000922	CcSEcCtD
Prednisone—Diabetes mellitus—Doxorubicin—uterine cancer	9.55e-05	0.000921	CcSEcCtD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.55e-05	0.00192	CbGpPWpGaD
Prednisone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	9.54e-05	0.00092	CcSEcCtD
Prednisone—Decreased appetite—Dactinomycin—uterine cancer	9.46e-05	0.000912	CcSEcCtD
Prednisone—Fatigue—Dactinomycin—uterine cancer	9.38e-05	0.000905	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	9.33e-05	0.00188	CbGpPWpGaD
Prednisone—Purpura—Epirubicin—uterine cancer	9.32e-05	0.000899	CcSEcCtD
Prednisone—Vascular purpura—Doxorubicin—uterine cancer	9.29e-05	0.000896	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	9.23e-05	0.00186	CbGpPWpGaD
Prednisone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	9.22e-05	0.000889	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	9.22e-05	0.00186	CbGpPWpGaD
Prednisone—Cardiac failure—Epirubicin—uterine cancer	9.2e-05	0.000887	CcSEcCtD
Prednisone—Lethargy—Epirubicin—uterine cancer	9.16e-05	0.000884	CcSEcCtD
Prednisone—Cardiac failure congestive—Doxorubicin—uterine cancer	9.16e-05	0.000884	CcSEcCtD
Prednisone—Nausea—Progesterone—uterine cancer	9.14e-05	0.000882	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	9.14e-05	0.00184	CbGpPWpGaD
Prednisone—Dexamethasone—CYP19A1—uterine cancer	9.08e-05	0.0317	CrCbGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	9.01e-05	0.00182	CbGpPWpGaD
Prednisone—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	8.98e-05	0.000866	CcSEcCtD
Prednisone—Osteoarthritis—Epirubicin—uterine cancer	8.98e-05	0.000866	CcSEcCtD
Prednisone—Feeling abnormal—Dactinomycin—uterine cancer	8.97e-05	0.000865	CcSEcCtD
Prednisone—Ill-defined disorder—Etoposide—uterine cancer	8.95e-05	0.000863	CcSEcCtD
Prednisone—HSD11B1—Metabolism—STK11—uterine cancer	8.92e-05	0.0018	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CYP19A1—uterine cancer	8.92e-05	0.0018	CbGpPWpGaD
Prednisone—Anaemia—Etoposide—uterine cancer	8.92e-05	0.00086	CcSEcCtD
Prednisone—Gastrointestinal pain—Dactinomycin—uterine cancer	8.9e-05	0.000858	CcSEcCtD
Prednisone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	8.87e-05	0.000855	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—SOCS3—uterine cancer	8.87e-05	0.00179	CbGpPWpGaD
Prednisone—Increased appetite—Doxorubicin—uterine cancer	8.84e-05	0.000853	CcSEcCtD
Prednisone—Affect lability—Epirubicin—uterine cancer	8.84e-05	0.000852	CcSEcCtD
Prednisone—Rash—Medroxyprogesterone Acetate—uterine cancer	8.79e-05	0.000848	CcSEcCtD
Prednisone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	8.79e-05	0.000847	CcSEcCtD
Prednisone—Headache—Medroxyprogesterone Acetate—uterine cancer	8.74e-05	0.000843	CcSEcCtD
Prednisone—Malaise—Etoposide—uterine cancer	8.7e-05	0.000839	CcSEcCtD
Prednisone—Face oedema—Epirubicin—uterine cancer	8.67e-05	0.000836	CcSEcCtD
Prednisone—Vertigo—Etoposide—uterine cancer	8.67e-05	0.000836	CcSEcCtD
Prednisone—Purpura—Doxorubicin—uterine cancer	8.62e-05	0.000831	CcSEcCtD
Prednisone—Body temperature increased—Dactinomycin—uterine cancer	8.6e-05	0.000829	CcSEcCtD
Prednisone—Abdominal pain—Dactinomycin—uterine cancer	8.6e-05	0.000829	CcSEcCtD
Prednisone—Cardiac arrest—Epirubicin—uterine cancer	8.54e-05	0.000824	CcSEcCtD
Prednisone—Cardiac failure—Doxorubicin—uterine cancer	8.51e-05	0.000821	CcSEcCtD
Prednisone—Mood swings—Epirubicin—uterine cancer	8.51e-05	0.00082	CcSEcCtD
Prednisone—Loss of consciousness—Etoposide—uterine cancer	8.48e-05	0.000818	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—uterine cancer	8.48e-05	0.000818	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.37e-05	0.00169	CbGpPWpGaD
Prednisone—Convulsion—Etoposide—uterine cancer	8.36e-05	0.000806	CcSEcCtD
Prednisone—Hypertension—Etoposide—uterine cancer	8.33e-05	0.000803	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	8.31e-05	0.000801	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—uterine cancer	8.31e-05	0.000801	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.29e-05	0.00167	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.29e-05	0.00167	CbGpPWpGaD
Prednisone—Nausea—Medroxyprogesterone Acetate—uterine cancer	8.29e-05	0.000799	CcSEcCtD
Prednisone—Dry skin—Epirubicin—uterine cancer	8.23e-05	0.000794	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—uterine cancer	8.18e-05	0.000789	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—uterine cancer	8.17e-05	0.000788	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	8.16e-05	0.000787	CcSEcCtD
Prednisone—Discomfort—Etoposide—uterine cancer	8.12e-05	0.000783	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—uterine cancer	8.02e-05	0.000774	CcSEcCtD
Prednisone—Hypersensitivity—Dactinomycin—uterine cancer	8.02e-05	0.000773	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.98e-05	0.00161	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	7.96e-05	0.00161	CbGpPWpGaD
Prednisone—Alanine aminotransferase increased—Epirubicin—uterine cancer	7.92e-05	0.000764	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—uterine cancer	7.92e-05	0.000764	CcSEcCtD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	7.91e-05	0.00159	CbGpPWpGaD
Prednisone—Cardiac arrest—Doxorubicin—uterine cancer	7.9e-05	0.000762	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.88e-05	0.00159	CbGpPWpGaD
Prednisone—Anaphylactic shock—Etoposide—uterine cancer	7.87e-05	0.000759	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—uterine cancer	7.87e-05	0.000759	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.84e-05	0.00158	CbGpPWpGaD
Prednisone—Infection—Etoposide—uterine cancer	7.82e-05	0.000754	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—uterine cancer	7.81e-05	0.000754	CcSEcCtD
Prednisone—Asthenia—Dactinomycin—uterine cancer	7.81e-05	0.000753	CcSEcCtD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	7.8e-05	0.00157	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—SMAD3—uterine cancer	7.75e-05	0.00156	CbGpPWpGaD
Prednisone—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	7.74e-05	0.00156	CbGpPWpGaD
Prednisone—Tachycardia—Etoposide—uterine cancer	7.69e-05	0.000741	CcSEcCtD
Prednisone—Skin disorder—Etoposide—uterine cancer	7.65e-05	0.000738	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—uterine cancer	7.62e-05	0.000735	CcSEcCtD
Prednisone—Hyperhidrosis—Etoposide—uterine cancer	7.61e-05	0.000734	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—uterine cancer	7.61e-05	0.000734	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—uterine cancer	7.56e-05	0.000729	CcSEcCtD
Prednisone—NR3C1—Circadian Clock—EP300—uterine cancer	7.51e-05	0.00151	CbGpPWpGaD
Prednisone—Anorexia—Etoposide—uterine cancer	7.51e-05	0.000724	CcSEcCtD
Prednisone—ALB—Folate Metabolism—MTHFR—uterine cancer	7.5e-05	0.00151	CbGpPWpGaD
Prednisone—Diarrhoea—Dactinomycin—uterine cancer	7.44e-05	0.000718	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	7.33e-05	0.000707	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—uterine cancer	7.33e-05	0.000707	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—uterine cancer	7.26e-05	0.0007	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—uterine cancer	7.23e-05	0.000697	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	7.22e-05	0.00146	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	7.22e-05	0.00145	CbGpPWpGaD
Prednisone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	7.2e-05	0.00145	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	7.16e-05	0.00144	CbGpPWpGaD
Prednisone—Paraesthesia—Etoposide—uterine cancer	7.07e-05	0.000682	CcSEcCtD
Prednisone—Weight increased—Epirubicin—uterine cancer	7.06e-05	0.000681	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	7.05e-05	0.00142	CbGpPWpGaD
Prednisone—Pancreatitis—Doxorubicin—uterine cancer	7.04e-05	0.000679	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—uterine cancer	7.02e-05	0.000677	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—uterine cancer	7e-05	0.000675	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	6.92e-05	0.0014	CbGpPWpGaD
Prednisone—Vomiting—Dactinomycin—uterine cancer	6.92e-05	0.000667	CcSEcCtD
Prednisone—Rash—Dactinomycin—uterine cancer	6.86e-05	0.000662	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	6.85e-05	0.00138	CbGpPWpGaD
Prednisone—Decreased appetite—Etoposide—uterine cancer	6.85e-05	0.00066	CcSEcCtD
Prednisone—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	6.82e-05	0.00137	CbGpPWpGaD
Prednisone—Fatigue—Etoposide—uterine cancer	6.79e-05	0.000655	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—uterine cancer	6.78e-05	0.000654	CcSEcCtD
Prednisone—Constipation—Etoposide—uterine cancer	6.73e-05	0.000649	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—uterine cancer	6.72e-05	0.000648	CcSEcCtD
Prednisone—HSD11B1—Metabolism—MTHFR—uterine cancer	6.7e-05	0.00135	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	6.66e-05	0.00134	CbGpPWpGaD
Prednisone—Weight increased—Doxorubicin—uterine cancer	6.54e-05	0.00063	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—uterine cancer	6.5e-05	0.000627	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	6.5e-05	0.00131	CbGpPWpGaD
Prednisone—Feeling abnormal—Etoposide—uterine cancer	6.49e-05	0.000626	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—uterine cancer	6.48e-05	0.000625	CcSEcCtD
Prednisone—Nausea—Dactinomycin—uterine cancer	6.46e-05	0.000623	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—uterine cancer	6.44e-05	0.000621	CcSEcCtD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.41e-05	0.00129	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	6.36e-05	0.00128	CbGpPWpGaD
Prednisone—Bradycardia—Epirubicin—uterine cancer	6.32e-05	0.00061	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—uterine cancer	6.28e-05	0.000605	CcSEcCtD
Prednisone—Urticaria—Etoposide—uterine cancer	6.26e-05	0.000603	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—uterine cancer	6.24e-05	0.000602	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—uterine cancer	6.22e-05	0.0006	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—uterine cancer	6.22e-05	0.0006	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—uterine cancer	6.21e-05	0.000599	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	6.19e-05	0.00125	CbGpPWpGaD
Prednisone—Connective tissue disorder—Epirubicin—uterine cancer	6.11e-05	0.000589	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.08e-05	0.00123	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	6.04e-05	0.00122	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	6.01e-05	0.00121	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	5.96e-05	0.0012	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.91e-05	0.00119	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—CCL2—uterine cancer	5.87e-05	0.00118	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PHF1—uterine cancer	5.87e-05	0.00118	CbGpPWpGaD
Prednisone—Bradycardia—Doxorubicin—uterine cancer	5.85e-05	0.000564	CcSEcCtD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.82e-05	0.00117	CbGpPWpGaD
Prednisone—Eye disorder—Epirubicin—uterine cancer	5.81e-05	0.00056	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—uterine cancer	5.8e-05	0.000559	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—uterine cancer	5.78e-05	0.000557	CcSEcCtD
Prednisone—Flushing—Epirubicin—uterine cancer	5.77e-05	0.000556	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—uterine cancer	5.75e-05	0.000554	CcSEcCtD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.74e-05	0.00116	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	5.66e-05	0.00114	CbGpPWpGaD
Prednisone—Asthenia—Etoposide—uterine cancer	5.65e-05	0.000545	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—uterine cancer	5.65e-05	0.000545	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—uterine cancer	5.64e-05	0.000544	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	5.61e-05	0.00113	CbGpPWpGaD
Prednisone—Immune system disorder—Epirubicin—uterine cancer	5.61e-05	0.000541	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.6e-05	0.00113	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	5.58e-05	0.00113	CbGpPWpGaD
Prednisone—Pruritus—Etoposide—uterine cancer	5.57e-05	0.000537	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—uterine cancer	5.55e-05	0.000535	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	5.51e-05	0.00111	CbGpPWpGaD
Prednisone—Alopecia—Epirubicin—uterine cancer	5.49e-05	0.000529	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	5.46e-05	0.0011	CbGpPWpGaD
Prednisone—Mental disorder—Epirubicin—uterine cancer	5.44e-05	0.000525	CcSEcCtD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	5.43e-05	0.00109	CbGpPWpGaD
Prednisone—Malnutrition—Epirubicin—uterine cancer	5.41e-05	0.000522	CcSEcCtD
Prednisone—Erythema—Epirubicin—uterine cancer	5.41e-05	0.000522	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—uterine cancer	5.39e-05	0.00052	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—uterine cancer	5.37e-05	0.000518	CcSEcCtD
Prednisone—Flushing—Doxorubicin—uterine cancer	5.34e-05	0.000514	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	5.27e-05	0.00106	CbGpPWpGaD
Prednisone—Angiopathy—Doxorubicin—uterine cancer	5.22e-05	0.000503	CcSEcCtD
Prednisone—Dizziness—Etoposide—uterine cancer	5.21e-05	0.000502	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—uterine cancer	5.19e-05	0.000501	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—uterine cancer	5.14e-05	0.000495	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—NDUFB11—uterine cancer	5.1e-05	0.00103	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SRD5A2—uterine cancer	5.1e-05	0.00103	CbGpPWpGaD
Prednisone—Vision blurred—Epirubicin—uterine cancer	5.1e-05	0.000492	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—uterine cancer	5.08e-05	0.00049	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	5.04e-05	0.00102	CbGpPWpGaD
Prednisone—Mental disorder—Doxorubicin—uterine cancer	5.04e-05	0.000486	CcSEcCtD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.03e-05	0.00101	CbGpPWpGaD
Prednisone—Ill-defined disorder—Epirubicin—uterine cancer	5.02e-05	0.000484	CcSEcCtD
Prednisone—Vomiting—Etoposide—uterine cancer	5.01e-05	0.000483	CcSEcCtD
Prednisone—Erythema—Doxorubicin—uterine cancer	5e-05	0.000483	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—uterine cancer	5e-05	0.000483	CcSEcCtD
Prednisone—Anaemia—Epirubicin—uterine cancer	5e-05	0.000482	CcSEcCtD
Prednisone—NR3C1—Gene Expression—CHD4—uterine cancer	4.99e-05	0.00101	CbGpPWpGaD
Prednisone—Agitation—Epirubicin—uterine cancer	4.97e-05	0.000479	CcSEcCtD
Prednisone—Rash—Etoposide—uterine cancer	4.96e-05	0.000479	CcSEcCtD
Prednisone—Dermatitis—Etoposide—uterine cancer	4.96e-05	0.000478	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.96e-05	0.000999	CbGpPWpGaD
Prednisone—Headache—Etoposide—uterine cancer	4.93e-05	0.000476	CcSEcCtD
Prednisone—Malaise—Epirubicin—uterine cancer	4.88e-05	0.00047	CcSEcCtD
Prednisone—Vertigo—Epirubicin—uterine cancer	4.86e-05	0.000469	CcSEcCtD
Prednisone—Syncope—Epirubicin—uterine cancer	4.85e-05	0.000468	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—uterine cancer	4.75e-05	0.000458	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—uterine cancer	4.72e-05	0.000455	CcSEcCtD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.72e-05	0.000951	CbGpPWpGaD
Prednisone—Convulsion—Epirubicin—uterine cancer	4.69e-05	0.000452	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.68e-05	0.000944	CbGpPWpGaD
Prednisone—Nausea—Etoposide—uterine cancer	4.68e-05	0.000451	CcSEcCtD
Prednisone—Hypertension—Epirubicin—uterine cancer	4.67e-05	0.00045	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	4.66e-05	0.00094	CbGpPWpGaD
Prednisone—Ill-defined disorder—Doxorubicin—uterine cancer	4.64e-05	0.000448	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—uterine cancer	4.63e-05	0.000446	CcSEcCtD
Prednisone—Myalgia—Epirubicin—uterine cancer	4.6e-05	0.000444	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—uterine cancer	4.6e-05	0.000444	CcSEcCtD
Prednisone—Agitation—Doxorubicin—uterine cancer	4.6e-05	0.000443	CcSEcCtD
Prednisone—Anxiety—Epirubicin—uterine cancer	4.59e-05	0.000442	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	4.57e-05	0.000441	CcSEcCtD
Prednisone—Discomfort—Epirubicin—uterine cancer	4.55e-05	0.000439	CcSEcCtD
Prednisone—Malaise—Doxorubicin—uterine cancer	4.51e-05	0.000435	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—uterine cancer	4.5e-05	0.000434	CcSEcCtD
Prednisone—Syncope—Doxorubicin—uterine cancer	4.49e-05	0.000433	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.44e-05	0.000895	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	4.43e-05	0.000893	CbGpPWpGaD
Prednisone—Anaphylactic shock—Epirubicin—uterine cancer	4.41e-05	0.000426	CcSEcCtD
Prednisone—Oedema—Epirubicin—uterine cancer	4.41e-05	0.000426	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—uterine cancer	4.4e-05	0.000424	CcSEcCtD
Prednisone—Infection—Epirubicin—uterine cancer	4.39e-05	0.000423	CcSEcCtD
Prednisone—Shock—Epirubicin—uterine cancer	4.34e-05	0.000419	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—uterine cancer	4.34e-05	0.000418	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—uterine cancer	4.33e-05	0.000417	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	4.32e-05	0.000872	CbGpPWpGaD
Prednisone—Hypertension—Doxorubicin—uterine cancer	4.32e-05	0.000417	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—uterine cancer	4.31e-05	0.000415	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—uterine cancer	4.29e-05	0.000413	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—uterine cancer	4.27e-05	0.000411	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—uterine cancer	4.26e-05	0.000411	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—uterine cancer	4.26e-05	0.000411	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—uterine cancer	4.25e-05	0.000409	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.23e-05	0.000408	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—uterine cancer	4.21e-05	0.000406	CcSEcCtD
Prednisone—Anorexia—Epirubicin—uterine cancer	4.21e-05	0.000406	CcSEcCtD
Prednisone—NR3C1—Gene Expression—SUZ12—uterine cancer	4.18e-05	0.000843	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	4.17e-05	0.00084	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	4.12e-05	0.00083	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.12e-05	0.00083	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	4.11e-05	0.000828	CbGpPWpGaD
Prednisone—Oedema—Doxorubicin—uterine cancer	4.08e-05	0.000394	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—uterine cancer	4.08e-05	0.000394	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	4.06e-05	0.000819	CbGpPWpGaD
Prednisone—Infection—Doxorubicin—uterine cancer	4.06e-05	0.000391	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.05e-05	0.000816	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.05e-05	0.000816	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.02e-05	0.000388	CcSEcCtD
Prednisone—Shock—Doxorubicin—uterine cancer	4.02e-05	0.000387	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—uterine cancer	4.01e-05	0.000386	CcSEcCtD
Prednisone—Insomnia—Epirubicin—uterine cancer	3.99e-05	0.000385	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—uterine cancer	3.99e-05	0.000384	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—uterine cancer	3.97e-05	0.000383	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—uterine cancer	3.96e-05	0.000382	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—uterine cancer	3.95e-05	0.000381	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	3.91e-05	0.000787	CbGpPWpGaD
Prednisone—Anorexia—Doxorubicin—uterine cancer	3.89e-05	0.000375	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—uterine cancer	3.89e-05	0.000375	CcSEcCtD
Prednisone—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.85e-05	0.000776	CbGpPWpGaD
Prednisone—Decreased appetite—Epirubicin—uterine cancer	3.84e-05	0.00037	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	3.81e-05	0.000767	CbGpPWpGaD
Prednisone—Fatigue—Epirubicin—uterine cancer	3.81e-05	0.000367	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	3.8e-05	0.000767	CbGpPWpGaD
Prednisone—Constipation—Epirubicin—uterine cancer	3.77e-05	0.000364	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.74e-05	0.000754	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTEN—uterine cancer	3.73e-05	0.000752	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.72e-05	0.000359	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—uterine cancer	3.69e-05	0.000356	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—STAR—uterine cancer	3.69e-05	0.000744	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKR1B1—uterine cancer	3.69e-05	0.000744	CbGpPWpGaD
Prednisone—Paraesthesia—Doxorubicin—uterine cancer	3.67e-05	0.000354	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.65e-05	0.000735	CbGpPWpGaD
Prednisone—Feeling abnormal—Epirubicin—uterine cancer	3.64e-05	0.000351	CcSEcCtD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.63e-05	0.000732	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.63e-05	0.000732	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.62e-05	0.000729	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Epirubicin—uterine cancer	3.61e-05	0.000348	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—uterine cancer	3.6e-05	0.000347	CcSEcCtD
Prednisone—HSD11B1—Metabolism—EP300—uterine cancer	3.56e-05	0.000717	CbGpPWpGaD
Prednisone—Decreased appetite—Doxorubicin—uterine cancer	3.55e-05	0.000342	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.52e-05	0.00071	CbGpPWpGaD
Prednisone—Fatigue—Doxorubicin—uterine cancer	3.52e-05	0.00034	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	3.51e-05	0.000708	CbGpPWpGaD
Prednisone—Urticaria—Epirubicin—uterine cancer	3.51e-05	0.000338	CcSEcCtD
Prednisone—Constipation—Doxorubicin—uterine cancer	3.49e-05	0.000337	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—uterine cancer	3.49e-05	0.000336	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—uterine cancer	3.49e-05	0.000336	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.49e-05	0.000703	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.4e-05	0.000686	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.37e-05	0.00068	CbGpPWpGaD
Prednisone—Feeling abnormal—Doxorubicin—uterine cancer	3.37e-05	0.000325	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.36e-05	0.000677	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.35e-05	0.000676	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Doxorubicin—uterine cancer	3.34e-05	0.000322	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	3.33e-05	0.000671	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	3.33e-05	0.000671	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.3e-05	0.000666	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	3.3e-05	0.000665	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	3.26e-05	0.000658	CbGpPWpGaD
Prednisone—Hypersensitivity—Epirubicin—uterine cancer	3.25e-05	0.000314	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—uterine cancer	3.24e-05	0.000313	CcSEcCtD
Prednisone—ALB—Platelet degranulation—VEGFA—uterine cancer	3.23e-05	0.000652	CbGpPWpGaD
Prednisone—Abdominal pain—Doxorubicin—uterine cancer	3.23e-05	0.000311	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—uterine cancer	3.23e-05	0.000311	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.17e-05	0.000639	CbGpPWpGaD
Prednisone—Asthenia—Epirubicin—uterine cancer	3.17e-05	0.000305	CcSEcCtD
Prednisone—Pruritus—Epirubicin—uterine cancer	3.12e-05	0.000301	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	3.1e-05	0.000625	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	3.09e-05	0.000623	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	3.08e-05	0.000621	CbGpPWpGaD
Prednisone—Diarrhoea—Epirubicin—uterine cancer	3.02e-05	0.000291	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—uterine cancer	3.01e-05	0.00029	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.97e-05	0.000599	CbGpPWpGaD
Prednisone—Asthenia—Doxorubicin—uterine cancer	2.93e-05	0.000283	CcSEcCtD
Prednisone—Dizziness—Epirubicin—uterine cancer	2.92e-05	0.000281	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—POLD1—uterine cancer	2.9e-05	0.000584	CbGpPWpGaD
Prednisone—Pruritus—Doxorubicin—uterine cancer	2.89e-05	0.000279	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.86e-05	0.000577	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—uterine cancer	2.85e-05	0.000574	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	2.83e-05	0.00057	CbGpPWpGaD
Prednisone—Vomiting—Epirubicin—uterine cancer	2.81e-05	0.000271	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—uterine cancer	2.79e-05	0.000269	CcSEcCtD
Prednisone—Rash—Epirubicin—uterine cancer	2.78e-05	0.000268	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—uterine cancer	2.78e-05	0.000268	CcSEcCtD
Prednisone—Headache—Epirubicin—uterine cancer	2.77e-05	0.000267	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—AKR1C1—uterine cancer	2.71e-05	0.000546	CbGpPWpGaD
Prednisone—Dizziness—Doxorubicin—uterine cancer	2.7e-05	0.00026	CcSEcCtD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.67e-05	0.000538	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CA—uterine cancer	2.63e-05	0.00053	CbGpPWpGaD
Prednisone—Nausea—Epirubicin—uterine cancer	2.62e-05	0.000253	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—uterine cancer	2.6e-05	0.00025	CcSEcCtD
Prednisone—Rash—Doxorubicin—uterine cancer	2.58e-05	0.000248	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—uterine cancer	2.57e-05	0.000248	CcSEcCtD
Prednisone—Headache—Doxorubicin—uterine cancer	2.56e-05	0.000247	CcSEcCtD
Prednisone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.51e-05	0.000505	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IRF1—uterine cancer	2.5e-05	0.000504	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.5e-05	0.000503	CbGpPWpGaD
Prednisone—ALB—Metabolism—SRD5A2—uterine cancer	2.49e-05	0.000503	CbGpPWpGaD
Prednisone—ALB—Metabolism—NDUFB11—uterine cancer	2.49e-05	0.000503	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.47e-05	0.000498	CbGpPWpGaD
Prednisone—Nausea—Doxorubicin—uterine cancer	2.43e-05	0.000234	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.42e-05	0.000488	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—RRM2—uterine cancer	2.41e-05	0.000487	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—DCN—uterine cancer	2.34e-05	0.000472	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	2.31e-05	0.000465	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.29e-05	0.000461	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.24e-05	0.000451	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.24e-05	0.000451	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP11A1—uterine cancer	2.21e-05	0.000445	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SRD5A2—uterine cancer	2.18e-05	0.00044	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NDUFB11—uterine cancer	2.18e-05	0.00044	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.17e-05	0.000438	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—uterine cancer	2.15e-05	0.000433	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.11e-05	0.000425	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKR1C3—uterine cancer	2.08e-05	0.00042	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PGR—uterine cancer	2.08e-05	0.00042	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.05e-05	0.000414	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—EZH2—uterine cancer	1.98e-05	0.000399	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR2—uterine cancer	1.83e-05	0.00037	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.83e-05	0.000369	CbGpPWpGaD
Prednisone—ALB—Metabolism—STAR—uterine cancer	1.8e-05	0.000363	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKR1B1—uterine cancer	1.8e-05	0.000363	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.78e-05	0.000359	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.7e-05	0.000342	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—STK11—uterine cancer	1.62e-05	0.000327	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.62e-05	0.000327	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—STAR—uterine cancer	1.62e-05	0.000326	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.62e-05	0.000326	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.6e-05	0.000323	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.6e-05	0.000322	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKR1B1—uterine cancer	1.58e-05	0.000318	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—STAR—uterine cancer	1.58e-05	0.000318	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.56e-05	0.000315	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.52e-05	0.000307	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CDKN2B—uterine cancer	1.49e-05	0.000301	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.49e-05	0.0003	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.45e-05	0.000293	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.43e-05	0.000289	CbGpPWpGaD
Prednisone—ALB—Metabolism—POLD1—uterine cancer	1.41e-05	0.000285	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.41e-05	0.000285	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SMAD3—uterine cancer	1.36e-05	0.000275	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.35e-05	0.000271	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.35e-05	0.000271	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKR1C1—uterine cancer	1.32e-05	0.000267	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—POLD1—uterine cancer	1.27e-05	0.000256	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—POLD1—uterine cancer	1.24e-05	0.00025	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—MTHFR—uterine cancer	1.22e-05	0.000246	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.2e-05	0.000242	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.19e-05	0.000239	CbGpPWpGaD
Prednisone—ALB—Metabolism—RRM2—uterine cancer	1.18e-05	0.000238	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKR1C1—uterine cancer	1.16e-05	0.000234	CbGpPWpGaD
Prednisone—ALB—Metabolism—DCN—uterine cancer	1.14e-05	0.000231	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.12e-05	0.000226	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR1—uterine cancer	1.11e-05	0.000224	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.1e-05	0.000222	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP11A1—uterine cancer	1.08e-05	0.000217	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.08e-05	0.000217	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.07e-05	0.000215	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—RRM2—uterine cancer	1.06e-05	0.000213	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—RRM2—uterine cancer	1.03e-05	0.000208	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—DCN—uterine cancer	1.03e-05	0.000207	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKR1C3—uterine cancer	1.02e-05	0.000205	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—DCN—uterine cancer	1e-05	0.000202	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKR1B1—uterine cancer	9.73e-06	0.000196	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—STAR—uterine cancer	9.73e-06	0.000196	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP11A1—uterine cancer	9.68e-06	0.000195	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP11A1—uterine cancer	9.45e-06	0.000191	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	9.15e-06	0.000184	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKR1C3—uterine cancer	9.14e-06	0.000184	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.01e-06	0.000182	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKR1C3—uterine cancer	8.93e-06	0.00018	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP19A1—uterine cancer	7.94e-06	0.00016	CbGpPWpGaD
Prednisone—ALB—Metabolism—STK11—uterine cancer	7.94e-06	0.00016	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EP300—uterine cancer	7.8e-06	0.000157	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—POLD1—uterine cancer	7.64e-06	0.000154	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.45e-06	0.00015	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—uterine cancer	7.39e-06	0.000149	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—uterine cancer	7.3e-06	0.000147	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.14e-06	0.000144	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—STK11—uterine cancer	7.12e-06	0.000144	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP19A1—uterine cancer	7.12e-06	0.000144	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.1e-06	0.000143	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP19A1—uterine cancer	6.95e-06	0.00014	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—STK11—uterine cancer	6.95e-06	0.00014	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—uterine cancer	6.79e-06	0.000137	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.69e-06	0.000135	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—EP300—uterine cancer	6.48e-06	0.000131	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.38e-06	0.000129	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RRM2—uterine cancer	6.37e-06	0.000128	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—uterine cancer	6.28e-06	0.000127	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—DCN—uterine cancer	6.18e-06	0.000125	CbGpPWpGaD
Prednisone—ALB—Metabolism—MTHFR—uterine cancer	5.96e-06	0.00012	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.82e-06	0.000117	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—uterine cancer	5.77e-06	0.000116	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—uterine cancer	5.58e-06	0.000113	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.5e-06	0.000111	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MTHFR—uterine cancer	5.35e-06	0.000108	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—uterine cancer	5.34e-06	0.000108	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.26e-06	0.000106	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MTHFR—uterine cancer	5.23e-06	0.000105	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	4.79e-06	9.66e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.72e-06	9.51e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—uterine cancer	4.72e-06	9.51e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.28e-06	8.64e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—STK11—uterine cancer	4.28e-06	8.64e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—uterine cancer	4.01e-06	8.08e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—uterine cancer	3.91e-06	7.89e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—uterine cancer	3.32e-06	6.69e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTHFR—uterine cancer	3.22e-06	6.49e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—EP300—uterine cancer	3.16e-06	6.38e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—uterine cancer	2.98e-06	6e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—uterine cancer	2.91e-06	5.86e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—EP300—uterine cancer	2.84e-06	5.73e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—EP300—uterine cancer	2.77e-06	5.59e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—uterine cancer	2.34e-06	4.72e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.1e-06	4.24e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—uterine cancer	2.05e-06	4.13e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—uterine cancer	1.91e-06	3.85e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—uterine cancer	1.79e-06	3.61e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—uterine cancer	1.72e-06	3.46e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—EP300—uterine cancer	1.71e-06	3.44e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—uterine cancer	1.68e-06	3.38e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.26e-06	2.55e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—uterine cancer	1.03e-06	2.08e-05	CbGpPWpGaD
